abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2010年5月30日

著者:
Solicitor General, US Department of Justice

[PDF] Pfizer Inc. v. Abdullahi, et al. - Brief for the United States as Amicus Curiae

This brief is filed in response to the Court’s order inviting the Solicitor General to express the views of the United States. In the view of the United States, the petition for a writ of certiorari should be denied…Neither of the questions presented warrants this Court’s review…Moreover, the procedural posture of the case counsels strongly against further review at this time. Not only is it possible that a decision by this Court would not even resolve the viability of respondents’ ATS claim for purposes of this case, but petitioner may still prevail on other dispositive questions…In addition, it is possible that the settlement process in Nigeria may render moot the claims in this case of some respondents. Review is thus unwarranted at this stage of the case.

タイムライン